找回密碼
 To register

QQ登錄

只需一步，快速開始

掃一掃，訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases; Christopher L. Cioffi Book 2020 Springer Nature Switzerlan

[復制鏈接]
查看: 7100|回復: 39
樓主
發(fā)表于 2025-3-21 17:52:28 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases
編輯Christopher L. Cioffi
視頻videohttp://file.papertrans.cn/284/283037/283037.mp4
概述Presents the current state of ocular drug therapy.Reviews the unique challenges faced for ocular drug discovery and delivery.Highlights future therapeutic opportunities for age-related macular degener
叢書名稱Topics in Medicinal Chemistry
圖書封面Titlebook: Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases; Christopher L. Cioffi Book 2020 Springer Nature Switzerlan
描述.This book reviews the current state of ocular drug therapy and future therapeutic opportunities for a wide variety of conditions, including Age-related Macular Degeneration, Diabetic Retinopathy and Macular Edema, Glaucoma, and Inherited Retinal Diseases..Retinal diseases are major contributors to moderate or severe vision impairment in adults aged 50 years and older. The respective patient populations for many of these indications is expected to significantly increase as the world population continues to grow older. An improved understanding of the etiological underpinnings of ocular degenerative diseases over the past decade has significantly bolstered ophthalmic drug discovery..In this volume, contributions from leading experts explore the unique challenges faced for ocular drug discovery and delivery providing the reader with detailed information on ocular pharmacokinetics, .in vitro, ex vivo. and .in vivo. models for retinal disease pathology and emerginggene therapy treatments. The book is intended for all researchers and clinicians who wish to increase their knowledge on the latest findings in ocular drug therapy..
出版日期Book 2020
關鍵詞Macular Degeneration; Stargardt Disease; Glaucoma; Diabetic Retinopathy; Diabetic Macular Edema; Ocular P
版次1
doihttps://doi.org/10.1007/978-3-030-56619-7
isbn_softcover978-3-030-56621-0
isbn_ebook978-3-030-56619-7Series ISSN 1862-2461 Series E-ISSN 1862-247X
issn_series 1862-2461
copyrightSpringer Nature Switzerland AG 2020
The information of publication is updating

書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影響因子(影響力)




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases影響因子(影響力)學科排名




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases網(wǎng)絡公開度




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases網(wǎng)絡公開度學科排名




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引頻次




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases被引頻次學科排名




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases年度引用學科排名




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases讀者反饋




書目名稱Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics
 

0票 0%

Better Implies Difficulty
 

0票 0%

Good and Satisfactory
 

0票 0%

Adverse Performance
 

0票 0%

Disdainful Garbage
您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:25:34 | 只看該作者
978-3-030-56621-0Springer Nature Switzerland AG 2020
板凳
發(fā)表于 2025-3-22 03:24:27 | 只看該作者
地板
發(fā)表于 2025-3-22 05:47:49 | 只看該作者
5#
發(fā)表于 2025-3-22 09:52:00 | 只看該作者
6#
發(fā)表于 2025-3-22 14:04:51 | 只看該作者
https://doi.org/10.1007/978-3-662-36243-3o major clinical presentations of AMD: atrophic or “dry” and neovascular or “wet.” Geographic atrophy (GA) is the most severe manifestation of dry AMD which represents the form of the disease characterized by the highest prevalence. A smaller fraction of AMD patients (10–20%) develop choroidal neova
7#
發(fā)表于 2025-3-22 17:03:15 | 只看該作者
8#
發(fā)表于 2025-3-22 22:18:26 | 只看該作者
9#
發(fā)表于 2025-3-23 04:21:14 | 只看該作者
https://doi.org/10.1007/978-3-662-36243-3but the number of clinical gene therapy trials has been very limited. The improved visual function outcomes in individuals affected by retinal dystrophy caused by biallelic variants in the RPE65 gene after gene therapy treatment contributed to the US Food and Drug Administration (FDA) and European M
10#
發(fā)表于 2025-3-23 06:25:27 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 09:48
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
涞源县| 巴东县| 姜堰市| 抚松县| 云浮市| 衢州市| 屏边| 晋宁县| 桂平市| 敦化市| 新和县| 霍林郭勒市| 寿光市| 故城县| 进贤县| 虞城县| 盐源县| 融水| 崇文区| 库尔勒市| 大同县| 牙克石市| 寿阳县| 通山县| 青州市| 左云县| 芦山县| 新邵县| 旌德县| 常德市| 阿城市| 黔江区| 调兵山市| 鄂伦春自治旗| 江孜县| 焦作市| 基隆市| 海阳市| 六枝特区| 高密市| 若尔盖县|